AstraZeneca to Develop Stem Cell Treatments
September 16, 2010
Submit Comments
It was announced on September 13, that AstraZeneca has become the second major pharmaceutical company, after Pfizer, to collaborate with the University College of London to develop stem cells, in this case, to treat diabetic retinopathy. (Pfizer’s work with UCL is for AMD.) To read all about the new collaboration, please see my update. (Link)
Print this post
Filed in Diabetes, Industry News, Macular Degeneration, New Technologies, Research, Retina, Stem Cell Therapies
Comments
Jump down to form below to submit your own comments
